Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples-Reference-Cited by-同舟云学术

Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

Published:2019-01-17 Issue:1 Volume:11 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Wolfsgruber Steffen^ORCID, ,Molinuevo José Luis,Wagner Michael,Teunissen Charlotte E.,Rami Lorena,Coll-Padrós Nina,Bouwman Femke H.,Slot Rosalinde E. R.,Wesselman Linda M. P.,Peters Oliver,Luther Katja,Buerger Katharina,Priller Josef,Laske Christoph,Teipel Stefan,Spottke Annika,Heneka Michael T.,Düzel Emrah,Drzezga Alexander,Wiltfang Jens,Sikkes Sietske A. M.,van der Flier Wiesje M.,Jessen Frank

Funder

JPND

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-018-0463-y.pdf

Reference35 articles.

1. Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions. Lancet Neurol. 2015;14:926–44. https://doi.org/10.1016/S1474-4422(15)00153-2 .

2. Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, et al. Prevention trials in Alzheimer's disease: an EU-US task force report. Prog Neurobiol. 2011;95:594–600. https://doi.org/10.1016/j.pneurobio.2011.08.014 .

3. Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535–62. https://doi.org/10.1016/j.jalz.2018.02.018 .